Smit VT - Search Results

1

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.

Stelloo E, Nout RA, Naves LC, Ter Haar NT, Creutzberg CL, Smit VT, Bosse T. Stelloo E, et al. Among authors: smit vt. Gynecol Oncol. 2014 May;133(2):197-204. doi: 10.1016/j.ygyno.2014.02.012. Epub 2014 Feb 18. Gynecol Oncol. 2014. PMID: 24556061

2

Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.

Abeln EC, Smit VT, Wessels JW, de Leeuw WJ, Cornelisse CJ, Fleuren GJ. Abeln EC, et al. Among authors: smit vt. J Pathol. 1997 Dec;183(4):424-31. doi: 10.1002/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-L. J Pathol. 1997. PMID: 9496259

3

Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.

Scholten AN, Creutzberg CL, Noordijk EM, Smit VT. Scholten AN, et al. Among authors: smit vt. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1067-74. doi: 10.1016/s0360-3016(01)02710-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 11958903

4

Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.

Scholten AN, Smit VT, Beerman H, van Putten WL, Creutzberg CL. Scholten AN, et al. Among authors: smit vt. Cancer. 2004 Feb 15;100(4):764-72. doi: 10.1002/cncr.20040. Cancer. 2004. PMID: 14770433 Free article.

5

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

Scholten AN, van Putten WL, Beerman H, Smit VT, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van Lent M, Creutzberg CL; PORTEC Study Group. Scholten AN, et al. Among authors: smit vt. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):834-8. doi: 10.1016/j.ijrobp.2005.03.007. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15927414 Clinical Trial.

6

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.

Nout RA, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, van Bunningen BN, Smit VT, Nijman HW, van den Tol PP, Creutzberg CL. Nout RA, et al. Among authors: smit vt. J Clin Oncol. 2009 Jul 20;27(21):3547-56. doi: 10.1200/JCO.2008.20.2424. Epub 2009 Jun 22. J Clin Oncol. 2009. PMID: 19546404 Clinical Trial.

7

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

Nout RA, Bosse T, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, van Eijk R, Ter Haar NT, Smit VT. Nout RA, et al. Among authors: smit vt. Gynecol Oncol. 2012 Sep;126(3):466-73. doi: 10.1016/j.ygyno.2012.05.012. Epub 2012 May 15. Gynecol Oncol. 2012. PMID: 22609107

8

Near-infrared fluorescence imaging of a solitary fibrous tumor of the pancreas using methylene blue.

van der Vorst JR, Vahrmeijer AL, Hutteman M, Bosse T, Smit VT, van de Velde CJ, Frangioni JV, Bonsing BA. van der Vorst JR, et al. Among authors: smit vt. World J Gastrointest Surg. 2012 Jul 27;4(7):180-4. doi: 10.4240/wjgs.v4.i7.180. World J Gastrointest Surg. 2012. PMID: 22905287 Free PMC article.

9

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

Bosse T, ter Haar NT, Seeber LM, v Diest PJ, Hes FJ, Vasen HF, Nout RA, Creutzberg CL, Morreau H, Smit VT. Bosse T, et al. Among authors: smit vt. Mod Pathol. 2013 Nov;26(11):1525-35. doi: 10.1038/modpathol.2013.96. Epub 2013 May 24. Mod Pathol. 2013. PMID: 23702729 Free article.

10

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era.

Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, Aghajanian C, Edmondson R, Goodfellow PJ, Quinn M, Salvesen HB, Thomas G; GCIG Endometrial Cancer Clinical Trials Planning Meeting. Creutzberg CL, et al. Int J Gynecol Cancer. 2013 Oct;23(8):1528-34. doi: 10.1097/IGC.0b013e3182a26edb. Int J Gynecol Cancer. 2013. PMID: 24257568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters